Nisa Investment Advisors
ARQT icon

Nisa Investment Advisors’s Arcutis Biotherapeutics ARQT Stock Holding History

Nisa Investment Advisors’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29K Buy
1,229
+3
+0.2% +$77 ﹤0.01% 1884
2025
Q4 		$35.6K Sell
1,226
-153
-11% -$3.92K ﹤0.01% 1729
2025
Q3 		$26K Hold
1,379
– – ﹤0.01% 1870
2025
Q2 		$19.3K Sell
1,379
-18
-1% -$252 ﹤0.01% 1954
2025
Q1 		$21.8K Buy
1,397
+28
+2% +$394 ﹤0.01% 1835
2024
Q4 		$19.1K Buy
1,369
+96
+8% +$1.05K ﹤0.01% 1949
2024
Q3 		$11.8K Buy
1,273
+205
+19% +$2.02K ﹤0.01% 2064
2024
Q2 		$9.93K Buy
1,068
+943
+754% +$8.53K ﹤0.01% 2155
2024
Q1 		$1.24K Buy
+125
New +$933 ﹤0.01% 2324
2023
Q3 		– Sell
-46
Closed -$438 – 2775
2023
Q2 		$438 Buy
+46
New +$511 ﹤0.01% 2585
2023
Q1 		– Sell
-13,900
Closed -$206K – 2523
2022
Q4 		$206K Sell
13,900
-35
-0.3% -$611 ﹤0.01% 1364
2022
Q3 		$266K Buy
13,935
+35
+0.3% +$793 ﹤0.01% 1201
2022
Q2 		$296K Hold
13,900
– – ﹤0.01% 1202
2022
Q1 		$268K Buy
+13,900
New +$235K ﹤0.01% 1265

Other funds holding ARQT

SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return